Department of Hematology and Oncology, Harbor-UCLA Medical Center and the David Geffen School of Medicine at UCLA, USA
Research Article
Thrombocytopenia in Non-Alcoholic Fatty Liver Disease (NAFLD)
Author(s): Sarah Tomassetti*, David Yashar, Katie LaBarbera and Elaina Van Patten
Non-alcoholic fatty liver disease (NAFLD) is quickly becoming the most common liver disease worldwide, with Hispanic
persons being the most effected. Current studies have shown conflicting results as to the incidence of thrombocytopenia
in patients with NAFLD. In this study, we aimed to evaluate the incidence of thrombocytopenia in
patients with NAFLD in a large Los Angeles safety-net hospital. To do this, we performed a retrospective chart review
of adult patients with the diagnosis of NAFLD based on imaging. Patients were excluded if they had cirrhosis, chronic
viral hepatitis, splenomegaly, excessive alcohol consumption, malignancy, consumption of drugs commonly associated
with thrombocytopenia, or known immune thrombocytopenia. We identified 560 patients with NAFLD. Of
those patients, 51.3% were Hispanic. The mean platelet count was 252.4 K/cumm for all patien.. View More»
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 